HRP20110405T1 - Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe - Google Patents
Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe Download PDFInfo
- Publication number
- HRP20110405T1 HRP20110405T1 HR20110405T HRP20110405T HRP20110405T1 HR P20110405 T1 HRP20110405 T1 HR P20110405T1 HR 20110405 T HR20110405 T HR 20110405T HR P20110405 T HRP20110405 T HR P20110405T HR P20110405 T1 HRP20110405 T1 HR P20110405T1
- Authority
- HR
- Croatia
- Prior art keywords
- seq
- polypeptide
- polypeptide according
- polynucleotide
- melanocortin receptor
- Prior art date
Links
- 102000004378 Melanocortin Receptors Human genes 0.000 title claims abstract 7
- 108090000950 Melanocortin Receptors Proteins 0.000 title claims abstract 7
- 238000000034 method Methods 0.000 title claims abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 claims abstract 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 18
- 102000040430 polynucleotide Human genes 0.000 claims abstract 8
- 108091033319 polynucleotide Proteins 0.000 claims abstract 8
- 239000002157 polynucleotide Substances 0.000 claims abstract 8
- 210000004027 cell Anatomy 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims 1
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 claims 1
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62196004P | 2004-10-25 | 2004-10-25 | |
| PCT/US2005/038431 WO2006047535A2 (fr) | 2004-10-25 | 2005-10-25 | Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110405T1 true HRP20110405T1 (hr) | 2011-06-30 |
Family
ID=36228385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110405T HRP20110405T1 (hr) | 2004-10-25 | 2011-05-31 | Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20060105951A1 (fr) |
| EP (1) | EP1812046B1 (fr) |
| JP (1) | JP2008517605A (fr) |
| KR (1) | KR101255140B1 (fr) |
| CN (1) | CN101437540B (fr) |
| AT (1) | ATE501731T1 (fr) |
| AU (1) | AU2005299440B2 (fr) |
| BR (1) | BRPI0518411A2 (fr) |
| CA (1) | CA2585287A1 (fr) |
| CY (1) | CY1111486T1 (fr) |
| DE (1) | DE602005026970D1 (fr) |
| DK (1) | DK1812046T3 (fr) |
| EA (1) | EA200700944A1 (fr) |
| EC (1) | ECSP077416A (fr) |
| ES (1) | ES2363023T3 (fr) |
| HK (1) | HK1106445A1 (fr) |
| HR (1) | HRP20110405T1 (fr) |
| IL (1) | IL182683A0 (fr) |
| MA (1) | MA28943B1 (fr) |
| ME (1) | ME01234B (fr) |
| MX (1) | MX2007004974A (fr) |
| NO (1) | NO20072499L (fr) |
| PL (1) | PL1812046T3 (fr) |
| PT (1) | PT1812046E (fr) |
| RS (1) | RS51789B (fr) |
| SI (1) | SI1812046T1 (fr) |
| TN (1) | TNSN07157A1 (fr) |
| WO (1) | WO2006047535A2 (fr) |
| ZA (1) | ZA200704260B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910101B2 (en) * | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| US7790671B2 (en) | 2005-10-07 | 2010-09-07 | Codman & Shurtleff, Inc. | Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| MX2010013436A (es) | 2008-06-09 | 2011-06-21 | Palatin Technologies Inc | Peptidos especificos del receptor de melanocortina para el tratamiento de disfuncion sexual. |
| US20090305960A1 (en) * | 2008-06-09 | 2009-12-10 | Palatin Technologies, Inc | Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669 |
| US8614185B2 (en) * | 2009-05-04 | 2013-12-24 | Centocor Ortho Biotech Inc. | Fusion proteins of alpha-MSH derivatives and Fc |
| BRPI1009644B1 (pt) | 2009-06-08 | 2022-02-08 | Palatin Technologies, Inc | Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica |
| EP2440572B1 (fr) | 2009-06-08 | 2017-04-05 | Palatin Technologies, Inc. | Peptides spécifiques des récepteurs aux mélanocortines à pont lactame |
| UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| EP2504351A4 (fr) | 2009-11-23 | 2013-10-30 | Palatin Technologies Inc | Peptides linéaires spécifiques du récepteur de la mélanocortine-1 |
| NZ599774A (en) | 2009-11-23 | 2014-11-28 | Palatin Technologies Inc | Melanocortin-1 receptor-specific cyclic peptides |
| JP2020141710A (ja) * | 2011-07-06 | 2020-09-10 | ゲンマブ エー／エス | 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節 |
| WO2020177627A1 (fr) * | 2019-03-02 | 2020-09-10 | 上海一宸医药科技有限公司 | Anticorps bispécifique |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1137340A4 (fr) * | 1998-12-09 | 2005-12-21 | Eleanor Roosevelt Inst | Composition et procedes de regulation du poids corporel et des pathologies associees |
| US7169603B2 (en) * | 2000-07-14 | 2007-01-30 | Mgi Pharma Biologics, Inc. | α-MSH related compounds and methods of use |
| WO2004002424A2 (fr) * | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Corps mimetiques d'epo de mammifere a deletion ch1, compositions, methodes et utilisations associees |
| WO2004002417A2 (fr) * | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations |
| KR20070004078A (ko) * | 2004-03-31 | 2007-01-05 | 센토코 인코포레이티드 | 인간 ｇｌｐ-1 모방체, 조성물, 방법 및 용도 |
-
2005
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active IP Right Cessation
- 2005-10-25 EP EP05819741A patent/EP1812046B1/fr active Active
- 2005-10-25 CA CA002585287A patent/CA2585287A1/fr not_active Abandoned
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/fr unknown
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 RS RS20110230A patent/RS51789B/en unknown
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/fr active Application Filing
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de active Active
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es active Active
-
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
- 2007-11-05 HK HK07112011.3A patent/HK1106445A1/xx not_active IP Right Cessation
-
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown
- 2011-05-31 HR HR20110405T patent/HRP20110405T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110405T1 (hr) | Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe | |
| ATE444361T1 (de) | Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen | |
| CY1114893T1 (el) | Παραγωγη ανθρωπινης γλυκοσερεμπροσιδασης υψηλης μαννοζης σε φυτικη καλλιεργεια | |
| DK2058323T3 (da) | Til MHC-molekyler bindende tumorassocierede peptider | |
| NO20043891L (no) | Anti-A-beta-antistoffer og deres anvendelse | |
| WO2004020595A3 (fr) | Nouveaux polypeptides humains codes par des polynucleotides | |
| PE20090763A1 (es) | Polipetidos, dominios variables de anticuerpos y antagonistas | |
| AUPR107800A0 (en) | Peptide and nucleic acid molecule ii | |
| RU2012127383A (ru) | Композиции и способы для увеличения времени полужизни fc-слитых белков в сыворотке | |
| DE60238993D1 (de) | Hybrid und tandemproteine von neisseria sp | |
| AR046833A1 (es) | Anticuerpos anti-interleuquina-10 | |
| EA200801571A1 (ru) | Композиции, содержащие молекулы ctl4-ig, и способы их получения | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| WO2004003147A3 (fr) | Polypeptides cngh0004, anticorps, compositions, procedes et utilisations | |
| MX2022012191A (es) | Partículas lipídicas dirigidas y composiciones y usos de estas. | |
| WO2003020932A1 (fr) | Nouvelles proteines de secretion et adn associe | |
| DK1511761T3 (da) | Fremgangsmåde til fremstilling af cykliske peptider | |
| ATE299029T1 (de) | Verfahren und zusammensetzungen zur peptidsynthese (t-20) | |
| DK2044125T3 (da) | Sammensætninger og fremgangsmåder til indgivelse af aktiverede anti-ras-antistoffer i celler | |
| AR042968A1 (es) | Anticuerpos de virus anti-dengue composiciones metodos y usos | |
| ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
| JP2008517605A5 (fr) | ||
| DE60045045D1 (de) | Nukleinsäuremoleküle zur kodierung cyclisierbare aminosäuresequenzen | |
| ATE397662T1 (de) | Neues polypeptid, dafür kodierende dna und deren verwendungen | |
| NO20021810D0 (no) | Skreddersydde peptidsyntetaser, fremgangsmåte for deres fremstilling og deres anvendelse |